Initial characterization of mice null for Lphn3, a gene implicated in ADHD and addiction

Brain Research

Volumn 1463, Issue , 2012, Pages 85-92

  Wallis, Deeann ^a   Hill, Denise S ^b   Mendez, Ian A ^a,e   Abbott, Louise C ^c   Finnell, Richard H ^b,f   Wellman, Paul J ^a   Setlow, Barry ^d  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Texas A and M College of Medicine   (United States)

^c TEXAS A AND M UNIVERSITY   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f The University of Texas at Austin   (United States)

Author keywords

Addiction; Attention deficit hyperactivity; disorder; Latrophilin; Lphn3

Indexed keywords

COCAINE; DOPAMINE RECEPTOR; DOPAMINE TRANSPORTER; LPHN3 PROTEIN; NCAM PROTEIN; NERVE PROTEIN; NURR PROTEIN; PROTEIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

ADDICTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENTION DEFICIT DISORDER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; EMBRYONIC STEM CELL; FEMALE; GENDER; GENE EXPRESSION; GENOTYPE; HYPERACTIVITY; LOCOMOTION; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; NULL ALLELE; OPEN FIELD TEST; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR, ADDICTIVE; COCAINE; DISEASE MODELS, ANIMAL; FEMALE; GENOTYPE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR ACTIVITY; MUTATION; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SIGNAL TRANSDUCTION;

MUS;

EID: 84861909408     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.04.053     Document Type: Article

References (45)

1. Anastasio, N.C., Stoffel, E.C., Fox, R.G., Bubar,M.J., Rice, K.C., Moeller, F.G., Cunningham, K.A., 2011. Serotonin (5-hydroxytryptamine) 5-HT(2A) receptor: association with inherent and cocaine-evoked behavioral disinhibition in rats. Behav. Pharmacol. 22, 248-261.
2. Arcos-Burgos,M., Jain,M., Acosta,M., Shively, S., Stanescu,H.,Wallis, D., Domené, S., Vélez, J., Karkera, J., Balog, J., Berg, K., Kleta, R., Gahl,W., Roessler, E., Long, R., Lie, J., Pineda, D., Londono, A., Palacio, J., Arbelaez, A., Lopera, F., Elia, J., Hakonarson, H., Johansson, S., Knappskog, P., Haavik, J., Ribases, M., Cormand, B., Bayes, M., Casas, M., Ramos-Quiroga, J., Hervas, A., Maher, B., Faraone, S., Seitz, C., Freitag, C., Palmason,H., Meyer, J.,Romanos, M., Walitza, S.,Hemminger, U.,Warnke,A., Romanos, J., Renner, T., Jacob, C.,Lesch,K.-P., Swanson, J.,Vortmeye, A.,Bailey-Wilson, J., Castellanos, F., Muenke, M., 2010. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 15, 1053-1066.
3. Bergen, A.W., Korczak, J.F., Weissbecker, K.A., Goldstein, A.M., 1999. A genome-wide search for loci contributing to smoking and alcoholism. Genet. Epidemiol. 17 (Suppl. 1), S55-S60.
4. Biederman, J., Faraone, S., Milberger, S., Curtis, S., Chen, L., Marrs, A., Ouellette, C., Moore, P., Spencer, T., 1996. Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. J. Am. Acad. Child Adolesc. Psychiatry 35, 343-351. (Pubitemid 26072292)
5. Bin Sun, H., Ruan, Y., Xu, Z.C., Yokota, H., 2002. Involvement of the calcium-independent receptor for alpha-latrotoxin in brain ischemia. Brain Res. Mol. Brain Res. 104, 246-249.
6. Bobb, A.J., Castellanos, F.X., Addington, A.M., Rapoport, J.L., 2005. Molecular genetic studies of ADHD: 1991 to 2004. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132, 109-125. (Pubitemid 40066207)
7. Chen, W.V., Delrow, J., Corrin, P.D., Frazier, J.P., Soriano, P., 2004. Identification and validation of PDGF transcriptional targets by microarray-coupled gene-trap mutagenesis. Nat. Genet. 36, 304-312. (Pubitemid 38282758)
8. Davids, E., Zhang, K., Tarazi, F.I., Baldessarini, R.J., 2003. Animal models of attention-deficit hyperactivity disorder. Brain Res. Brain Res. Rev. 42, 1-21. (Pubitemid 36369262)
9. Domené, S., Stanescu, H., Wallis, D., Tinloy, B., Pineda, D.E., Kleta, R., Arcos-Burgos, M., Roessler, E., Muenke, M., 2011. Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility. Neuropsychiatr. Genet. 156B, 11-18.
10. Dudek, B.C., Phillips, T.J., Hahn, M.E., 1991. Genetic analyses of the biphasic nature of the alcohol dose-response curve. Alcohol. Clin. Exp. Res. 15, 262-269.
11. Eells, J.B., 2003. The control of dopamine neuron development, function and survival: insights from transgenic mice and the relevance to human disease. Curr. Med. Chem. 10, 857-870. (Pubitemid 36443240)
12. Franke, B., Neale, B.M., Faraone, S.V., 2009. Genome-wide association studies in ADHD. Hum. Genet. 126, 13-50.
13. Gainetdinov, R.R., Jones, S.R., Caron, M.G., 1999. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol. Psychiatry 46, 303-311. (Pubitemid 29335911)
14. Hill, J.C., Schoener, E.P., 1996. Age-dependent decline of attention deficit hyperactivity disorder. Am. J. Psychiatry 153, 1143-1146. (Pubitemid 26299832)
15. Ichtchenko, K., Bittner, M.A., Krasnoperov, V., Little, A.R., Chepurny, O., Holz, R.W., Petrenko, A.G., 1999. A novel ubiquitously expressed alpha-latrotoxin receptor is a member of the CIRL family of G-protein-coupled receptors. J. Biol. Chem. 274, 5491-5498. (Pubitemid 29109196)
16. Jain, M., Palacio, L.G., Castellanos, F.X., Palacio, J.D., Pineda, D., Restrepo, M.I., Munoz, J.F., Lopera, F., Wallis, D., Berg, K., Bailey-Wilson, J.E., Arcos-Burgos, M., Muenke, M., 2007. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci. Biol. Psychiatry 61, 1329-1339. (Pubitemid 46855764)
17. Jain, M., Velez, J.I., Acosta, M.T., Palacio, L.G., Balog, J., Roessler, E., Pineda, D., Londono, A.C., Palacio, J.D., Arbelaez, A., Lopera, F., Elia, J., Hakonarson, H., Seitz, C., Freitag, C.M., Palmason, H., Meyer, J., Romanos, M., Walitza, S., Hemminger, U., Warnke, A., Romanos, J., Renner, T., Jacob, C., Lesch, K.P., Swanson, J., Castellanos, F.X., Bailey-Wilson, J.E., Arcos-Burgos, M., Muenke, M., 2011. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol. Psychiatry 1-7.
18. Johnson, C., Drgon, T., Liu, Q.R., Walther, D., Edenberg, H., Rice, J., Foroud, T., Uhl, G.R., 2006. Pooled association genome scanning for alcohol dependence using 104,268 SNPs: validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 844-853. (Pubitemid 44905437)
19. Kan, Z., Jaiswal, B., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H., Yue, P., Haverty, P., Bourgon, R., Zheng, J., Moorhead, M., Chaudhuri, S., Tomsho, L., Peters, B., Pujara, K., Cordes, S., Davis, D., Carlton, V., Yuan, W., Li, L., Wang, W., Eigenbrot, C., Kaminker, J., Eberhard, D., Waring, P., Schuster, S., Modrusan, Z., Zhang, Z., Stokoe, D., de Sauvage, F., Faham, M., Seshagiri, S., 2010. Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466, 869-873.
20. Kramer, P.R., Guan, G., Wellman, P.J., Bellinger, L.L., 2007. Nicotine's attenuation of body weight involves the perifornical hypothalamus. Life Sci. 81, 500-508. (Pubitemid 47175974)
21. Krasnoperov, V.G., Bittner,M.A., Beavis, R., Kuang, Y., Salnikow, K.V., Chepurny, O.G., Little, A.R., Plotnikov, A.N.,Wu, D., Holz, R.W., Petrenko, A.G., 1997. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 18, 925-937. (Pubitemid 27274611)
22. Krasnoperov, V., Lu, Y., Buryanovsky, L., Neubert, T.A., Ichtchenko, K., Petrenko, A.G., 2002. Post-translational proteolytic processing of the calcium-independent receptor of alpha-latrotoxin (CIRL), a natural chimera of the cell adhesion protein and the G protein-coupled receptor. Role of the G protein-coupled receptor proteolysis site (GPS) motif. J. Biol. Chem. 277, 46518-46526. (Pubitemid 35417649)
23. Lange, M., Norton, W., Coolen, M., Chaminade, M., Merker, S., Proft, F., Schmitt, A., Vernier, P., Lesch, K.P., Bally-Cuif, L., 2012. The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development. Mol. Psychiatry (Epub ahead of print).
24. Lelianova, V.G., Davletov, B.A., Sterling, A., Rahman, M.A., Grishin, E.V., Totty, N.F., Ushkaryov, Y.A., 1997. Alpha-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors. J. Biol. Chem. 272, 21504-21508. (Pubitemid 27374024)
25. Liu, Q.R., Drgon, T., Johnson, C.,Walther, D., Hess, J., Uhl, G.R., 2006. Addiction molecular genetics: 639,401 SNP whole genome association identifiesmany "cell adhesion" genes. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 918-925. (Pubitemid 44905448)
26. Long, J.C., Knowler, W.C., Hanson, R.L., Robin, R.W., Urbanek, M., Moore, E., Bennett, P.H., Goldman, D., 1998. Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am. J. Med. Genet. 81, 216-221. (Pubitemid 28211181)
27. Matsushita,H., Lelianova,V.G.,Ushkaryov,Y.A., 1999.The latrophilin family: multiply spliced G protein-coupled receptors with differential tissue distribution. FEBS Lett. 443, 348-352. (Pubitemid 29080824)
28. Matzel, L.D., Babiarz, J., Townsend, D.A., Grossman, H.C., Grumet, M., 2008. Neuronal cell adhesion molecule deletion induces a cognitive and behavioral phenotype reflective of impulsivity. Genes Brain Behav. 7, 470-480. (Pubitemid 351590934)
29. Mill, J., 2007. Rodent models: utility for candidate gene studies in human attention-deficit hyperactivity disorder (ADHD). J. Neurosci. Methods 166, 294-305. (Pubitemid 350016392)
30. O'Sullivan, M.L., deWit, J., Savas, J.N., Comoletti, D., Otto-Hitt, S., Yates III, J.R., Ghosh, A., 2012. FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development. Neuron 73, 903-910.
31. Phillips, T.J., Huson, M.G., McKinnon, C.S., 1998. Localization of genes mediating acute and sensitized locomotor responses to cocaine in BXD/Ty recombinant inbred mice. J. Neurosci. 18, 3023-3034. (Pubitemid 28163232)
32. Reich, T., Edenberg, H.J., Goate, A.,Williams, J.T., Rice, J.P., Van Eerdewegh, P., Foroud, T., Hesselbrock, V., Schuckit, M.A., Bucholz,K., Porjesz, B., Li, T.K.,Conneally, P.M., Nurnberger Jr., J.I., Tischfield, J.A., Crowe, R.R., Cloninger, C.R., Wu,W., Shears, S., Carr, K., Crose, C.,Willig, C., Begleiter, H., 1998. Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet. 81, 207-215. (Pubitemid 28211180)
33. Russell, V.A., 2007.Neurobiology of animalmodels of attention-deficit hyperactivity disorder. J. Neurosci. Methods 161, 185-198. (Pubitemid 46466956)
34. Russell, V.A., 2011. Overview of animal models of attention deficit hyperactivity disorder (ADHD). Curr Protoc Neurosci Chapter 9: Unit9 35.
35. Shah, Z.A., Gilani, R.A., Sharma, P., Vohora, S.B., 2005. Attenuation of stress-elicited brain catecholamines, serotonin and plasma corticosterone levels by calcined gold preparations used in Indian system of medicine. Basic Clin. Pharmacol. Toxicol. 96, 469-474. (Pubitemid 40835702)
36. Sudhof, T.C., 2001. alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins. Annu. Rev. Neurosci. 24, 933-962. (Pubitemid 32695249)
37. Sved, A.F., 1989. PNMT-containing catecholaminergic neurons are not necessarily adrenergic. Brain Res. 481, 113-118. (Pubitemid 19060573)
38. Uhl, G.R., 2004a. Molecular genetic underpinnings of human substance abuse vulnerability: likely contributions to understanding addiction as a mnemonic process. Neuropharmacology 47 (Suppl. 1), 140-147. (Pubitemid 39298260)
39. Uhl, G.R., 2004b.Molecular genetics of substance abuse vulnerability: remarkable recent convergence of genome scan results. Ann. N. Y. Acad. Sci. 1025, 1-13. (Pubitemid 39643839)
40. Uhl, G.R., Drgon, T., Johnson, C., Fatusin, O.O., Liu, Q.R., Contoreggi, C., Li, C.Y., Buck, K., Crabbe, J., 2008a. "Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice. Biochem. Pharmacol. 75, 98-111. (Pubitemid 350235391)
41. Uhl, G.R., Drgon, T., Liu, Q.R., Johnson, C., Walther, D., Komiyama, T., Harano, M., Sekine, Y., Inada, T., Ozaki, N., Iyo, M., Iwata, N., Yamada, M., Sora, I., Chen, C.K., Liu, H.C., Ujike, H., Lin, S.K., 2008b. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry 65, 345-355.
42. van der Kooij, M.A., Glennon, J.C., 2007. Animal models concerning the role of dopamine in attention-deficit hyperactivity disorder. Neurosci. Biobehav. Rev. 31, 597-618. (Pubitemid 46527883)
43. Wallis, D., Russell, H.F., Muenke, M., 2008. Review: genetics of attention deficit/hyperactivity disorder. J. Pediatr. Psychol. 33, 1085-1099.
44. Werme, M., Hermanson, E., Carmine, A., Buervenich, S., Zetterstrom, R.H., Thoren, P., Ogren, S.O., Olson, L., Perlmann, T., Brene, S., 2003. Decreased ethanol preference andwheel running in Nurr1-deficient mice. Eur. J. Neurosci. 17, 2418-2424. (Pubitemid 36793750)
45. Xing, Y., Nakamura, Y., Rainey, W.E., 2009. G protein-coupled receptor expression in the adult and fetal adrenal glands. Mol. Cell. Endocrinol. 300, 43-50.